SCHULMAN, S., & KEARON, C. (2005). Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients. Journal of thrombosis and haemostasis, 3(4), 692-694. https://doi.org/10.1111/j.1538-7836.2005.01204.x
Citace podle Chicago (17th ed.)SCHULMAN, S., a C. KEARON. "Definition of Major Bleeding in Clinical Investigations of Antihemostatic Medicinal Products in Non‐surgical Patients." Journal of Thrombosis and Haemostasis 3, no. 4 (2005): 692-694. https://doi.org/10.1111/j.1538-7836.2005.01204.x.
Citace podle MLA (9th ed.)SCHULMAN, S., a C. KEARON. "Definition of Major Bleeding in Clinical Investigations of Antihemostatic Medicinal Products in Non‐surgical Patients." Journal of Thrombosis and Haemostasis, vol. 3, no. 4, 2005, pp. 692-694, https://doi.org/10.1111/j.1538-7836.2005.01204.x.